Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentPreface
View the documentIntroduction
Open this folder and view contentsParasitic infections
Open this folder and view contentsInsect and arachnid bites and stings
Open this folder and view contentsSuperficial fungal infections
Open this folder and view contentsSubcutaneous fungal infections
Open this folder and view contentsBacterial infections
Open this folder and view contentsViral infections
Open this folder and view contentsEczematous diseases
Open this folder and view contentsScaling diseases
Open this folder and view contentsPapulosquamous diseases
View the documentCutaneous reactions to drugs
Open this folder and view contentsPigmentary disorders
Open this folder and view contentsPremalignant lesions and malignant tumours
Open this folder and view contentsPhotodermatoses
Open this folder and view contentsBullous dermatoses
View the documentAlopecia areata
View the documentUrticaria
Open this folder and view contentsConditions common in children
View the documentAcne vulgaris
View the documentPruritus
View the documentTropical ulcers
Open this folder and view contentsAntimicrobial drugs
Open this folder and view contentsAntifugal drugs
Open this folder and view contentsAntiseptic agents
Open this folder and view contentsKeratoplastic and keratolytic agents
Open this folder and view contentsScabicides and pediculicides
Open this folder and view contentsAnti-inflammatory and antipruritic drugs1
Open this folder and view contentsAntiallergics and drugs used in anaphylaxis
Open this folder and view contentsUltraviolet radiation-blocking agents (sunscreens)
Open this folder and view contentsMiscellaneous drugs
Open this folder and view contentsAnnex
View the documentSelected WHO Publications of Related Interest
View the documentBack cover
 

Introduction

Considerable progress has been made in the treatment of skin diseases. Nevertheless, such diseases still remain common in many rural communities in developing countries, with serious economic and social consequences as well as health implications. Directly or indirectly, skin diseases are responsible for much disability (and loss of economic potential), disfigurement, and distress due to symptoms such as itching or pain.

The diseases covered in this volume are mostly very common, although some rare, life-threatening disorders such as pemphigus are discussed briefly. The aim is to provide the basic information necessary to treat skin diseases in the community, with particular emphasis on those diseases prevalent in developing countries. The book does not attempt to provide a detailed guide to the management of skin diseases.

Given reliable access to preparations contained in WHO’s Model List of Essential Drugs,1 many skin diseases are curable or controllable. However, it is recognized that factors such as poor housing, inadequate nutrition, unsanitary conditions and environmental pollution may also contribute to the prevalence of such diseases and should also be addressed when required.

1The use of essential drugs. Seventh report of the WHO Expert Committee. Geneva, World Health Organization, 1997 (WHO Technical Report Series, No. 867).

In general, conditions in which skin involvement is only one manifestation of a more generalized systemic infectious disease, such as leprosy, mycobacterial diseases, leishmaniasis, onchocerciasis, human immunodeficiency virus (HIV) infection and syphilis, are excluded from this volume. Further details of the treatment of some of these conditions can be found in the volumes on drugs used in mycobacterial diseases,1 parasitic diseases2 and sexually transmitted diseases and HIV infection.3

1WHO model prescribing information: drugs used in mycobacterial diseases. Geneva, World Health Organization, 1991.

2WHO model prescribing information: drugs used in parasitic diseases, 2nd ed. Geneva, World Health Organization, 1995.

3WHO model prescribing information: drugs used in sexually transmitted diseases and HIV infection. Geneva, World Health Organization, 1995.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019